Department of Cardiology, Peking University First Hospital, Beijing.
People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang.
J Hypertens. 2021 Oct 1;39(10):2015-2021. doi: 10.1097/HJH.0000000000002891.
Secondary hypertension has emerged as a major public health problem in China. Early diagnosis and treatment can significantly improve the clinical outcomes. However, data on the current cause composition in China are seldom reported.
To describe the trends in cause-related comorbidities in hospitalized patients with secondary hypertension in China from 2013 to 2016.
This was a retrospective analysis based on the national Hospital Quality Monitoring System (HQMS) database, which collects information from the front pages of in-hospital medical records. Hospitalized patients with secondary hypertension from 746 tertiary hospitals that consistently uploaded data to the HQMS from 2013 to 2016 were enrolled. All diagnoses were identified using International Classification of Diseases version 10 (ICD-10) diagnostic codes. Descriptive analyses were used to determine the proportions of secondary hypertension causes and changing trends over 4 years.
The study collected data on 402 371 hospitalized patients with secondary hypertension from the HQMS during 2013-2016. Secondary hypertension caused by renal parenchymal disease ranked first and accounted for more than 50%. Obstructive sleep apnea syndrome (OSAS) followed closely with a rate of approximately 25%. Primary aldosteronism presented the highest proportion among all causes of endocrine hypertension. Regarding longitudinal changes over time, the rates of renal hypertension showed a significant downward trend from 2013 to 2016 (P < 0.001). In contrast, OSAS, endocrine hypertension, renal vascular disease, and aorta diseases maintained a significant upward trend from 2013 to 2016 (P < 0.001). The rates of these diseases in women with common secondary hypertension was higher than that of men, except in patients with OSAS (P < 0.001). In addition, renal parenchymal diseases and renal vascular diseases gradually decreased with age, whereas OSAS and aortic diseases gradually increased with age. The proportion of endocrine hypertension in the middle-aged group was higher than the other two age groups.
The study provides important information on the changing trends of cause rate of secondary hypertension modified by age and sex in China during 2013-2016. Renal parenchymal disease is still the most common cause of secondary hypertension with a decreasing trend, followed by OSAS with an increasing trend.
继发性高血压已成为中国的一个主要公共卫生问题。早期诊断和治疗可以显著改善临床结局。然而,目前中国关于病因构成的数据很少有报道。
描述 2013 年至 2016 年中国继发性高血压住院患者相关病因构成的变化趋势。
这是一项基于国家医院质量监测系统(HQMS)数据库的回顾性分析,该数据库从住院病历首页采集信息。纳入 2013 年至 2016 年期间,746 家三级医院持续向 HQMS 上传数据的继发性高血压住院患者。所有诊断均采用国际疾病分类第 10 版(ICD-10)诊断代码确定。采用描述性分析确定 4 年间继发性高血压病因的构成比例及其变化趋势。
本研究从 HQMS 中收集了 2013 年至 2016 年期间 402371 例继发性高血压住院患者的数据。由肾实质疾病引起的继发性高血压位居首位,占比超过 50%。阻塞性睡眠呼吸暂停综合征(OSAS)紧随其后,占比约为 25%。原发性醛固酮增多症在所有内分泌性高血压病因中所占比例最高。关于随时间纵向变化,2013 年至 2016 年肾性高血压的比例呈显著下降趋势(P<0.001)。相比之下,OSAS、内分泌性高血压、肾血管疾病和主动脉疾病自 2013 年至 2016 年呈显著上升趋势(P<0.001)。除 OSAS 患者外(P<0.001),女性常见继发性高血压患者中这些疾病的发病率高于男性。此外,肾实质疾病和肾血管疾病随年龄增长逐渐下降,而 OSAS 和主动脉疾病随年龄增长逐渐增加。中年组内分泌性高血压的比例高于其他两个年龄组。
本研究提供了 2013 年至 2016 年中国按年龄和性别修正的继发性高血压病因构成变化趋势的重要信息。肾实质疾病仍然是继发性高血压最常见的病因,呈下降趋势,其次是 OSAS,呈上升趋势。